In two academic papers, a team of researchers led by Newcastle University demonstrates how Artificial Intelligence can determine the course and severity of aggressive skin cancers, such as Merkel cell carcinoma (MCC). This enhanced clinical decision-making by generating personalised predictions of treatment-specific outcomes for patients and their doctors. The international team combined machine learning with clinical expertise to develop the web-based system called “DeepMerkel” which…